Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Opioid modulators for alcohol dependence.

Hillemacher T, Heberlein A, Muschler MA, Bleich S, Frieling H.

Expert Opin Investig Drugs. 2011 Aug;20(8):1073-86. doi: 10.1517/13543784.2011.592139. Epub 2011 Jun 9. Review.

PMID:
21651459
2.

Preclinical validation of a novel cocaine exposure therapy for relapse prevention.

Mihindou C, Vouillac C, Koob GF, Ahmed SH.

Biol Psychiatry. 2011 Sep 15;70(6):593-8. doi: 10.1016/j.biopsych.2011.03.036. Epub 2011 May 14.

3.

30-year trajectories of heroin and other drug use among men and women sampled from methadone treatment in California.

Grella CE, Lovinger K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):251-8. doi: 10.1016/j.drugalcdep.2011.04.004. Epub 2011 May 6.

4.

Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference.

Laaksonen E, Lahti J, Sinclair JD, Heinälä P, Alho H.

Alcohol Alcohol. 2011 May-Jun;46(3):308-11. doi: 10.1093/alcalc/agq101. Epub 2011 Jan 25.

PMID:
21266377
5.

Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal.

Paronis CA, Bergman J.

J Pharmacol Exp Ther. 2011 Feb;336(2):488-95. doi: 10.1124/jpet.110.173823. Epub 2010 Nov 4.

6.

Representation of sweet and salty taste intensity in the brain.

Spetter MS, Smeets PA, de Graaf C, Viergever MA.

Chem Senses. 2010 Nov;35(9):831-40. doi: 10.1093/chemse/bjq093. Epub 2010 Sep 27.

PMID:
20876393
7.
8.

Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.

Shin AC, Pistell PJ, Phifer CB, Berthoud HR.

Neuroscience. 2010 Oct 13;170(2):580-8. doi: 10.1016/j.neuroscience.2010.07.017. Epub 2010 Jul 27.

9.

Hedonic and motivational roles of opioids in food reward: implications for overeating disorders.

Peciña S, Smith KS.

Pharmacol Biochem Behav. 2010 Nov;97(1):34-46. doi: 10.1016/j.pbb.2010.05.016. Epub 2010 May 24. Review.

PMID:
20580734
10.

Naltrexone implants compared to methadone: outcomes six months after prison release.

Lobmaier PP, Kunøe N, Gossop M, Katevoll T, Waal H.

Eur Addict Res. 2010;16(3):139-45. doi: 10.1159/000313336. Epub 2010 Apr 26.

PMID:
20424458
11.

Long-acting depot formulations of naltrexone for heroin dependence: a review.

Krupitsky EM, Blokhina EA.

Curr Opin Psychiatry. 2010 May;23(3):210-4. doi: 10.1097/YCO.0b013e3283386578. Review.

PMID:
20224403
12.

Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.

Hulse GK, Morris N, Arnold-Reed D, Tait RJ.

Arch Gen Psychiatry. 2009 Oct;66(10):1108-15. doi: 10.1001/archgenpsychiatry.2009.130.

PMID:
19805701
13.

Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.

King A, Cao D, Vanier C, Wilcox T.

Alcohol Clin Exp Res. 2009 Jun;33(6):1044-50. doi: 10.1111/j.1530-0277.2009.00925.x. Epub 2009 Mar 19.

14.

Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.

Garbutt JC, Osborne M, Gallop R, Barkenbus J, Grace K, Cody M, Flannery B, Kampov-Polevoy AB.

Alcohol Alcohol. 2009 May-Jun;44(3):293-300. doi: 10.1093/alcalc/agn122. Epub 2009 Feb 3.

15.

Dissecting components of reward: 'liking', 'wanting', and learning.

Berridge KC, Robinson TE, Aldridge JW.

Curr Opin Pharmacol. 2009 Feb;9(1):65-73. doi: 10.1016/j.coph.2008.12.014. Epub 2009 Jan 21. Review.

16.

Gender Differences Among In- and Out-of-Treatment Opioid-Addicted Individuals.

Kelly SM, Schwartz RP, O'Grady KE, Mitchell SG, Reisinger HS, Peterson JA, Agar MH, Brown BS.

Am J Drug Alcohol Abuse. 2009;35(1):38-42. doi: 10.1080/00952990802342915.

17.

Sex differences in drug addiction: a review of animal and human studies.

Fattore L, Altea S, Fratta W.

Womens Health (Lond). 2008 Jan;4:51-65. doi: 10.2217/17455057.4.1.51. Review.

PMID:
19072451
18.

Sustained-release naltrexone for opioid dependence.

Lobmaier P, Kornør H, Kunøe N, Bjørndal A.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006140. doi: 10.1002/14651858.CD006140.pub2. Review.

PMID:
18425938
19.

Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people.

Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K.

Arch Gen Psychiatry. 2008 Apr;65(4):466-75. doi: 10.1001/archpsyc.65.4.466.

20.

Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.

Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, Loughead J, O'Brien CP, Childress AR.

Am J Psychiatry. 2008 Mar;165(3):390-4. Epub 2007 Dec 3.

PMID:
18056224

Supplemental Content

Support Center